Tirosint 200 MCG Oral Capsule

RxCUI: 1923052
RxNorm name: Tirosint 200 MCG Oral Capsule
Display name: Tirosint 200 MCG Oral Capsule
Full name: Tirosint 200 MCG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tirosint	LEVOTHYROXINE SODIUM	IBSA Pharma Inc.	7a7ade79-0165-4e31-b84e-667416c00c7e	2026-03-25	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1923052

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7a7ade79-0165-4e31-b84e-667416c00c7e	Tirosint 200 MCG Oral Capsule	PSN	13	These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000	20260325
7a7ade79-0165-4e31-b84e-667416c00c7e	Tirosint 0.2 MG Oral Capsule	SY	13	These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000	20260325
7a7ade79-0165-4e31-b84e-667416c00c7e	Tirosint 200 MCG Oral Capsule	SY	13	These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000	20260325
7a7ade79-0165-4e31-b84e-667416c00c7e	levothyroxine sodium 0.2 MG Oral Capsule [Tirosint]	SBD	13	These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000	20260325